{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:23:08Z","timestamp":1775841788187,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ijbiomac.2020.12.131","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T23:10:16Z","timestamp":1608333016000},"page":"371-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Vaccine targeting TNF epitope 1\u201314 do not suppress host defense against Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin infection"],"prefix":"10.1016","volume":"169","author":[{"given":"Bing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaman","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengchong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5\u20136","key":"10.1016\/j.ijbiomac.2020.12.131_bb0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2011.09.004","article-title":"Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1","volume":"22","author":"Van Hauwermeiren","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2020.12.131_bb0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrrheum.2014.123","article-title":"Adverse reactions to biologic agents and their medical management","volume":"10","author":"Boyman","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ijbiomac.2020.12.131_bb0025","doi-asserted-by":"crossref","unstructured":"G. C. de Gannes, M. Ghoreishi, J. Pope, FRCPC; A. Russell, D. Bell, S. Adams, K. Shojania, M. Martinka, J. P. Dutz, Psoriasis and pustular dermatitis triggered by TNF-\u03b1 inhibitors in patients with rheumatologic conditions, Arch. Dermatol., 143 (2007) 223\u2013231.","DOI":"10.1001\/archderm.143.2.223"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.131_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.crohns.2010.11.001","article-title":"Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect","volume":"5","author":"Iborra","year":"2011","journal-title":"J. Crohns Colitis"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.131_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0961203313517153","article-title":"Subacute lupus erythematosus during treatment with golimumab for seronegative rheumatoid arthritis","volume":"23","author":"Brunasso","year":"2014","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.131_bb0040","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s00125-009-1381-0","article-title":"Development of type 1 diabetes in a patient treated with anti-TNF-\u03b1 therapy for active rheumatoid arthritis","volume":"52","author":"Tack","year":"2009","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ijbiomac.2020.12.131_bb0045","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijbiomac.2020.12.131_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214802","article-title":"Parkinsonism as a side effect of infliximab","volume":"2016","author":"Henriksen","year":"2016","journal-title":"BMJ Case Rep."},{"issue":"10","key":"10.1016\/j.ijbiomac.2020.12.131_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006156","article-title":"Sarcoidosis associated with infliximab therapy in ulcerative colitis: a case report","volume":"96","author":"Gilca","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-3768-y","article-title":"A case report of severe recurrent varicella in an ankylosing spondylitis patient treated with adalimumab - a new side effect after 15 years of usage","volume":"19","author":"Skuhala","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/art.20764","article-title":"Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report","volume":"52","author":"Catrina","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.131_bb0070","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn\u2019s disease","volume":"124","author":"Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2020.12.131_bb0075","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/10878","article-title":"Therapeutic antibodies elicited by immunization against TNF-alpha","volume":"17","author":"Dalum","year":"1999","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.131_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellimm.2007.05.005","article-title":"Prepared and screened a modified TNF-alpha molecule as TNF-alpha autovaccine to treat LPS induced endotoxic shock and TNF-alpha induced cachexia in mouse","volume":"246","author":"Wan","year":"2007","journal-title":"Cell. Immunol."},{"issue":"32","key":"10.1016\/j.ijbiomac.2020.12.131_bb0085","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1073\/pnas.0804157105","article-title":"Immunochemical termination of self-tolerance","volume":"105","author":"Gr\u00fcnewald","year":"2008","journal-title":"PNAS"},{"issue":"23\u201324","key":"10.1016\/j.ijbiomac.2020.12.131_bb0090","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/j.vaccine.2004.01.064","article-title":"Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection","volume":"22","author":"Capini","year":"2004","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.12.131_bb0095","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.4049\/jimmunol.178.11.7450","article-title":"A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis","volume":"178","author":"Spohn","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.12.131_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163080","article-title":"A rationally designed TNF-alpha epitope-scaffold Immunogen induces sustained antibody response and alleviates collagen-induced arthritis in mice","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2020.12.131_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.09.031","article-title":"Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers","volume":"149","author":"Mora-Solano","year":"2017","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.131_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cytogfr.2013.12.005","article-title":"Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice","volume":"25","author":"Winsauer","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.131_bb0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrd3030","article-title":"TNF receptor 2 pathway: drug target for autoimmune diseases","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"34","key":"10.1016\/j.ijbiomac.2020.12.131_bb0120","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1016\/j.biomaterials.2009.08.041","article-title":"The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF","volume":"30","author":"Shibata","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2009.12.015","article-title":"Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice","volume":"149","author":"Nomura","year":"2011","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0130","doi-asserted-by":"crossref","first-page":"H743","DOI":"10.1152\/ajpheart.00166.2007","article-title":"Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction","volume":"293","author":"Monden","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2020.12.131_bb0135","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00251-001-0423-7","article-title":"Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively","volume":"53","author":"Sashio","year":"2002","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1750-3639.2008.00151.x","article-title":"Tumor necrosis factor alpha is reparative via TNFR1 in the hippocampus and via TNFR2 in the striatum after virus-induced encephalitis","volume":"19","author":"Rodriguez","year":"2009","journal-title":"Brain Pathol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.131_bb0145","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.4049\/jimmunol.168.7.3394","article-title":"Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-alpha","volume":"168","author":"Olleros","year":"2002","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.12.131_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031469","article-title":"Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF and TNF receptors comparing two memTNF molecules","volume":"7","author":"Olleros","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.131_bb0155","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/315324","article-title":"Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins","volume":"3","author":"Diethelm-Okita","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.131_bb0160","article-title":"Recombinant costimulatory fusion proteins as functional immunomodulators enhance antitumor activity in murine B16F10 melanoma","volume":"8","author":"Cai","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2020.12.131_bb0165","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3389\/fimmu.2019.02472","article-title":"The immunogenicity and anti-tumor efficacy of a rationally designed neoantigen vaccine for B16F10 mouse melanoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.131_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00262-016-1928-0","article-title":"Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor models","volume":"66","author":"Xu","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"Database","key":"10.1016\/j.ijbiomac.2020.12.131_bb0175","doi-asserted-by":"crossref","first-page":"D1164","DOI":"10.1093\/nar\/gkq888","article-title":"IEDB-3D: structural data within the immune epitope database","volume":"39","author":"Ponomarenko","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.131_bb0180","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat. Protoc."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0185","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: new development for protein structure and function predictions","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"5 Suppl1","key":"10.1016\/j.ijbiomac.2020.12.131_bb0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semarthrit.2005.01.009","article-title":"Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab","volume":"34","author":"Wallis","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ijbiomac.2020.12.131_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/srep01809","article-title":"Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection","volume":"3","author":"Allie","year":"2013","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ijbiomac.2020.12.131_bb0200","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.4049\/jimmunol.174.8.4852","article-title":"Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection","volume":"174","author":"Saunders","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.12.131_bb0205","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3389\/fimmu.2017.01533","article-title":"Tumor necrosis factor-alpha targeting can protect against arthritis with low sensitization to infection","volume":"8","author":"Belmellat","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.131_bb0210","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/597204","article-title":"Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guerin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis","volume":"199","author":"Olleros","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.131_bb0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.131_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0040039","article-title":"Human innate Mycobacterium tuberculosis-reactive alphabetaTCR+ thymocytes","volume":"4","author":"Gold","year":"2008","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.131_bb0225","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jhep.2010.05.029","article-title":"Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis","volume":"53","author":"Olleros","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2020.12.131_bb0230","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.3389\/fimmu.2019.02550","article-title":"CD3(+) macrophages deliver proinflammatory cytokines by a CD3- and transmembrane TNF-dependent pathway and are increased at the BCG-infection site","volume":"10","author":"Rodriguez-Cruz","year":"2019","journal-title":"Front. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020353022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020353022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:33:01Z","timestamp":1758875581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020353022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":46,"alternative-id":["S0141813020353022"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.131","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine targeting TNF epitope 1\u201314 do not suppress host defense against Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}